Researchers are working to advance CAR-T therapy for prostate cancer, focusing on overcoming the tumor microenvironment to enhance efficacy. Studies and grants are being conducted to develop next-generation CAR T-cell therapies, with some institutions and researchers receiving awards and funding to support this work. The development of CAR-T cell therapy is part of a broader effort to improve immunotherapy and cancer treatment, with various organizations and researchers contributing to the field.